FDA Approves New Epilepsy Drug
<i> Associated Press</i>
WASHINGTON —
The first new epilepsy drug in more than 10 years was approved by the Food and Drug Administration on Monday.
The drug, felbamate, will be prescribed to prevent partial seizures in adults. It was also approved for use to treat a rare form of epilepsy in children known as Lennox-Gastaut syndrome.
About 2.5 million Americans have epilepsy and 125,000 new patients are found to have the disease each year.
Wallace Laboratories of Cranbury, N.J., will market the new drug under the brand name Felbatol.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
